# FDA Inspection 1286524 - JAMES & JAMES - October 01, 2025

Source: https://www.keypedia.com/records/fda_inspections/james-james/157ae6df-e421-418d-8c8d-9b4ef26ef17c
Source feed: FDA_Inspections

> FDA Inspection 1286524 for JAMES & JAMES on October 01, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1286524
- Company Name: JAMES & JAMES
- Inspection Date: 2025-10-01
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1289314 - 2025-10-16](https://www.keypedia.com/records/fda_inspections/james-james/9437e4ba-ffe7-417d-a89e-dbb8ad1bbb14)
- [FDA Inspection 1250597 - 2024-09-27](https://www.keypedia.com/records/fda_inspections/james-james/b570b09c-26ff-4771-a855-de852ccaf37e)
- [FDA Inspection 1203812 - 2023-04-18](https://www.keypedia.com/records/fda_inspections/james-james/0705e663-5df6-4f8b-a65f-c4140e82203d)
- [FDA Inspection 1200781 - 2023-03-27](https://www.keypedia.com/records/fda_inspections/james-james/a621bf60-e912-4a64-9276-59e6ab731e9f)

Company: https://www.keypedia.com/companies/james-james/8a013159-bf1e-4124-933e-4729829f5ae0

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c